MBIO MUSTANG BIO, INC.
Nasdaq · SEC CIK 1680048 · EDGAR
- Bought, last 12 months
- $237.12 1 purchases by 1 insiders
- Sold, last 12 months
- $240.92 2 sales by 2 insiders
- Filings on record
- 37 since 2021-07-08, latest 2026-04-27 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Jin David | Dir | $237.12 | — |
| Herskowitz Neil | Dir | — | $237.12 |
| Chill Adam J. | Dir | — | $3.80 |
| Litchman Manuel MD | Pres, CEO, Interim CFO, Dir | — | — |
| Fortress Biotech, Inc. | 10% | — | — |
Transactions 40
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 16:05 | 2026-04-24 | MBIO | Litchman Manuel MD | Pres, CEO, Interim CFO, Dir | F - Tax | $0.75 | -19 | 1,615 | -1% | -$14.25 | |
| 2026-01-05 | 2026-01-02 | MBIO | Fortress Biotech, Inc. | 10% | A - Grant | $0.00 | +278.4K | 536.6K | +108% | $0 | |
| 2025-12-30 | 2025-12-30 | MBIO | Chill Adam J. | Dir | S - Sale | $0.95 | -4 | 375 | -1% | -$3.80 | |
| 2025-12-30 | 2025-12-30 | MBIO | Herskowitz Neil | Dir | S - Sale | $0.96 | -247 | 145 | -63% | -$237.12 | |
| 2025-12-30 | 2025-12-30 | MBIO | Jin David | Dir | P - Purchase | $0.96 | +247 | 286 | +633% | +$237.12 | |
| 2025-10-01 | 2025-09-29 | MBIO | Fortress Biotech, Inc. | 10% | A - Grant | $0.00 | +59.3K | 258.2K | +30% | $0 | |
| 2025-04-28 | 2025-04-24 | MBIO | Litchman Manuel MD | Pres, CEO, Interim CFO, Dir | F - Tax | $1.24 | -27 | 1,634 | -2% | -$33.48 | |
| 2025-04-02 | 2025-03-31 | MBIO | Fortress Biotech, Inc. | 10% | A - Grant | $0.00 | +67.8K | 198.9K | +52% | $0 | |
| 2024-06-28 | 2024-06-27 | MBIO | Fortress Biotech, Inc. | 10% | A - Grant | $0.00 | +575.2K | 2.50M | +30% | $0 | |
| 2024-06-04 | 2024-05-31 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | F - Tax | $0.35 | -1,396 | 83.0K | -2% | -$488.60 | |
| M | 2024-06-04 | 2022-04-24+ | MBIO | Litchman Manuel MD | Pres, CEO, Dir | F - Tax | $7.72 | -2,820 | 81.0K | -3% | -$21.8K |
| 2024-01-03 | 2024-01-02 | MBIO | Fortress Biotech, Inc. | 10% | A - Grant | $0.00 | +419.1K | 1.93M | +28% | $0 | |
| 2023-07-07 | 2023-07-05 | MBIO | ZELEFSKY MICHAEL J | Dir | A - Grant | $0.00 | +7,246 | 19.0K | +62% | $0 | |
| I | 2023-07-07 | 2023-07-05 | MBIO | WEISS MICHAEL S | Dir | A - Grant | $0.00 | +7,246 | 49.6K | +17% | $0 |
| 2023-07-07 | 2023-07-05 | MBIO | ROSENWALD LINDSAY A MD | Dir | A - Grant | $0.00 | +7,246 | 60.5K | +14% | $0 | |
| 2023-07-07 | 2023-04-24 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | A - Grant | $0.00 | +5,000 | 111.1K | +5% | $0 | |
| 2023-07-07 | 2023-07-05 | MBIO | Herskowitz Neil | Dir | A - Grant | $0.00 | +7,246 | 19.7K | +58% | $0 | |
| 2023-07-07 | 2023-07-05 | MBIO | Chill Adam J. | Dir | A - Grant | $0.00 | +7,246 | 19.2K | +61% | $0 | |
| 2023-04-03 | 2022-07-29 | MBIO | ROSENWALD LINDSAY A MD | Dir | A - Grant | $0.00 | +71.7K | 294.2K | +32% | $0 | |
| M | 2023-04-03 | 2022-03-18+ | MBIO | ROSENWALD LINDSAY A MD | Dir | P - Purchase | $0.619 | +9,094 | 299.2K | +3% | +$5,630 |
| I | 2023-04-03 | 2022-07-29 | MBIO | WEISS MICHAEL S | Dir | A - Grant | $0.00 | +71.7K | 135.9K | +112% | $0 |
| M | 2023-04-03 | 2022-03-18+ | MBIO | Litchman Manuel MD | Dir | P - Purchase | $0.63 | +10.0K | 1.10M | +0.9% | +$6,300 |
| 2023-04-03 | 2022-06-21 | MBIO | Litchman Manuel MD | Dir | A - Grant | $0.00 | +61.0K | 1.09M | +6% | $0 | |
| 2023-04-03 | 2022-07-29 | MBIO | Herskowitz Neil | Dir | A - Grant | $0.00 | +71.7K | 186.9K | +62% | $0 | |
| 2023-04-03 | 2022-07-29 | MBIO | Chill Adam J. | Dir | A - Grant | $0.00 | +71.7K | 178.9K | +67% | $0 | |
| 2023-04-03 | 2022-07-29 | MBIO | ZELEFSKY MICHAEL J | Dir | A - Grant | $0.00 | +71.7K | 175.9K | +69% | $0 | |
| 2023-01-06 | 2023-01-06 | MBIO | Fortress Biotech, Inc. | 10% | A - Grant | $0.00 | +2.81M | 22.63M | +14% | $0 | |
| 2021-12-16 | 2021-12-14 | MBIO | Achenbach Brian | SVP, Fin, Corp. Ctrl | S - Sale | $1.83 | -4,374 | 144.7K | -3% | -$8,004 | |
| 2021-12-16 | 2021-12-08 | MBIO | Achenbach Brian | SVP, Fin, Corp. Ctrl | A - Grant | $0.00 | +22.5K | 149.1K | +18% | $0 | |
| 2021-11-08 | 2021-10-27 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | P - Purchase | $2.24 | +65.0K | 1.03M | +7% | +$145.6K | |
| 2021-10-21 | 2021-10-12 | MBIO | Achenbach Brian | SVP, Fin, Corp. Ctrl | S - Sale | $2.28 | -4,450 | 126.6K | -3% | -$10.1K | |
| 2021-09-24 | 2021-08-31 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | A - Grant | $2.58 | +2,746 | 963.0K | +0.3% | +$7,085 | |
| 2021-09-24 | 2021-08-31 | MBIO | ROSENWALD LINDSAY A MD | Dir | A - Grant | $2.58 | +1,170 | 218.4K | +0.5% | +$3,019 | |
| 2021-08-05 | 2021-07-30 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | P - Purchase | $2.91 | +86.2K | 960.2K | +10% | +$250.9K | |
| 2021-07-08 | 2021-06-28 | MBIO | ZELEFSKY MICHAEL J | Dir | A - Grant | $0.00 | +13.8K | 104.2K | +15% | $0 | |
| 2021-07-08 | 2021-06-28 | MBIO | Chill Adam J. | Dir | A - Grant | $0.00 | +13.8K | 107.2K | +15% | $0 | |
| 2021-07-08 | 2021-06-28 | MBIO | Herskowitz Neil | Dir | A - Grant | $0.00 | +13.8K | 115.2K | +14% | $0 | |
| 2021-07-08 | 2021-06-17 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | A - Grant | $0.00 | +61.0K | 874.0K | +8% | $0 | |
| 2021-07-08 | 2021-06-28 | MBIO | ROSENWALD LINDSAY A MD | Dir | A - Grant | $0.00 | +13.8K | 217.3K | +7% | $0 | |
| I | 2021-07-08 | 2021-06-28 | MBIO | WEISS MICHAEL S | Dir | A - Grant | $0.00 | +13.8K | 64.2K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations